;PMID: 3395131
;source_file_839.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..43] = [t:0..43]
;1)sentence:[e:49..217] = [t:49..217]
;2)section:[e:221..318] = [t:221..318]
;3)section:[e:322..394] = [t:322..394]
;4)sentence:[e:398..547] = [t:398..547]
;5)sentence:[e:548..868] = [t:548..868]
;6)sentence:[e:869..1006] = [t:869..1006]
;7)sentence:[e:1007..1150] = [t:1007..1150]
;8)sentence:[e:1151..1367] = [t:1151..1367]
;9)sentence:[e:1368..1525] = [t:1368..1525]
;10)section:[e:1529..1573] = [t:1529..1573]

;section 0 Span:0..43
;Arch Biochem Biophys. 1988 Jul;264(1):61-6.
(SEC
  (FRAG (NNP:[0..4] Arch) (NNP:[5..12] Biochem) (NNP:[13..20] Biophys)
        (.:[20..21] .) (CD:[22..26] 1988) (::[27..35] Jul;264-LRB-)
        (CD:[35..36] 1) (-RRB-:[36..37] -RRB-) (CD:[37..40] :61) (::[40..41] -)
        (CD:[41..43] 6.)))

;sentence 1 Span:49..217
;Immunochemical similarity of P-450 HFLa, a form of cytochrome P-450 in human 
;fetal livers, to a form of rat liver cytochrome P-450 inducible by macrolide 
;antibiotics.
;[78..88]:cyp450:"P-450 HFLa"
;[100..116]:cyp450:"cytochrome P-450"
;[164..180]:cyp450:"cytochrome P-450"
;[194..216]:substance:"macrolide  antibiotics"
(SENT
  (NP-HLN
    (NP (JJ:[49..63] Immunochemical) (NN:[64..74] similarity))
    (PP (IN:[75..77] of)
      (NP
        (NP (NN:[78..83] P-450) (NN:[84..88] HFLa))
        (,:[88..89] ,)
        (NP
          (NP (DT:[90..91] a) (NN:[92..96] form))
          (PP (IN:[97..99] of)
            (NP (NN:[100..110] cytochrome) (NN:[111..116] P-450)))
          (PP-LOC (IN:[117..119] in)
            (NP (JJ:[120..125] human) (JJ:[127..132] fetal)
                (NNS:[133..139] livers))))))
    (,:[139..140] ,)
    (PP (TO:[141..143] to)
      (NP
        (NP (DT:[144..145] a) (NN:[146..150] form))
        (PP (IN:[151..153] of)
          (NP (NN:[154..157] rat) (NN:[158..163] liver)
             (NN:[164..174] cytochrome) (NN:[175..180] P-450)))
        (ADJP (JJ:[181..190] inducible)
          (PP (IN:[191..193] by)
            (NP (NN:[194..203] macrolide) (NNS:[205..216] antibiotics))))))
    (.:[216..217] .)))

;section 2 Span:221..318
;Kitada M, Igoshi N, Kamataki T, Itahashi K, Imaoka S, Komori M, Funae Y, 
;Rikihisa T, Kanakubo Y.
(SEC
  (FRAG (NNP:[221..227] Kitada) (NNP:[228..230] M,) (NNP:[231..237] Igoshi)
        (NNP:[238..239] N) (,:[239..240] ,) (NNP:[241..249] Kamataki)
        (NNP:[250..251] T) (,:[251..252] ,) (NNP:[253..261] Itahashi)
        (NNP:[262..263] K) (,:[263..264] ,) (NNP:[265..271] Imaoka)
        (NNP:[272..274] S,) (NNP:[275..281] Komori) (NNP:[282..284] M,)
        (NNP:[285..290] Funae) (NNP:[291..292] Y) (,:[292..293] ,)
        (NNP:[295..303] Rikihisa) (NNP:[304..305] T) (,:[305..306] ,)
        (NNP:[307..315] Kanakubo) (NNP:[316..318] Y.)))

;section 3 Span:322..394
;Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
(SEC
  (FRAG (IN:[322..329] Faculty) (IN:[330..332] of)
        (NNP:[333..347] Pharmaceutical) (NNPS:[348..356] Sciences)
        (,:[356..357] ,) (NNP:[358..366] Hokkaido) (NNP:[367..377] University)
        (,:[377..378] ,) (NNP:[379..386] Sapporo) (,:[386..387] ,)
        (NNP:[388..393] Japan) (.:[393..394] .)))

;sentence 4 Span:398..547
;A protein immunochemically related to P-450 HFLa, a form of cytochrome P-450 
;purified from human fetal livers, was detected in rat liver microsomes.
;[400..407]:substance:"protein"
;[436..446]:cyp450:"P-450 HFLa"
;[458..474]:cyp450:"cytochrome P-450"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[398..399] A) (NN:[400..407] protein))
      (ADJP
        (ADVP (RB:[408..424] immunochemically))
        (JJ:[425..432] related)
        (NP (-NONE-:[432..432] *))
        (PP-CLR (TO:[433..435] to)
          (NP
            (NP (NN:[436..441] P-450) (NN:[442..446] HFLa))
            (,:[446..447] ,)
            (NP
              (NP
                (NP (DT:[448..449] a) (NN:[450..454] form))
                (PP (IN:[455..457] of)
                  (NP (NN:[458..468] cytochrome) (NN:[469..474] P-450))))
              (VP (VBN:[476..484] purified)
                (NP (-NONE-:[484..484] *))
                (PP (IN:[485..489] from)
                  (NP (JJ:[490..495] human) (JJ:[496..501] fetal)
                      (NNS:[502..508] livers)))))))))
    (,:[508..509] ,)
    (VP (VBD:[510..513] was)
      (VP (VBN:[514..522] detected)
        (NP-1 (-NONE-:[522..522] *))
        (PP-LOC (IN:[523..525] in)
          (NP (NN:[526..529] rat) (NN:[530..535] liver)
              (NNS:[536..546] microsomes)))))
    (.:[546..547] .)))

;sentence 5 Span:548..868
;The  content of the immunoreactive protein in rat liver microsomes was
;increased by  treatments with phenobarbital, pregnenolone 16
;alpha-carbonitrile (PCN),  erythromycin, erythromycin estolate, and
;oleandomycin but not with  3-methylcholanthrene, imidazole, ethanol,
;isosafrole, josamycin, midecamycin, or  miocamycin.
;[583..590]:substance:"protein"
;[649..662]:substance:"phenobarbital"
;[664..698]:substance:"pregnenolone 16 alpha-carbonitrile"
;[700..703]:substance:"PCN"
;[707..719]:substance:"erythromycin"
;[721..742]:substance:"erythromycin estolate"
;[748..760]:substance:"oleandomycin"
;[775..795]:substance:"3-methylcholanthrene"
;[797..806]:substance:"imidazole"
;[808..815]:substance:"ethanol"
;[817..827]:substance:"isosafrole"
;[829..838]:substance:"josamycin"
;[840..851]:substance:"midecamycin"
;[857..867]:substance:"miocamycin"
(SENT
  (S
    (NP-SBJ-2
      (NP (DT:[548..551] The) (NN:[553..560] content))
      (PP (IN:[561..563] of)
        (NP
          (NP (DT:[564..567] the) (JJ:[568..582] immunoreactive)
              (NN:[583..590] protein))
          (PP-LOC (IN:[591..593] in)
            (NP (NN:[594..597] rat) (NN:[598..603] liver)
                (NNS:[604..614] microsomes))))))
    (VP (VBD:[615..618] was)
      (NP-2 (-NONE-:[618..618] *))
      (VP
        (VP (VBN:[619..628] increased)
          (NP-2 (-NONE-:[628..628] *))
          (PP (IN:[629..631] by)
            (NP-LGS
              (NP (NNS:[633..643] treatments))
              (PP=1 (IN:[644..648] with)
                (NP
                  (NP (NN:[649..662] phenobarbital))
                  (,:[662..663] ,)
                  (NP
                    (NP
                      (NML (NN:[664..676] pregnenolone) (CD:[677..679] 16))
                      (NN:[680..698] alpha-carbonitrile))
                    (NP (-LRB-:[699..700] -LRB-) (NN:[700..703] PCN)
                        (-RRB-:[703..704] -RRB-)))
                  (,:[704..705] ,)
                  (NP (NN:[707..719] erythromycin))
                  (,:[719..720] ,)
                  (NP (NN:[721..733] erythromycin) (NN:[734..742] estolate))
                  (,:[742..743] ,) (CC:[744..747] and)
                  (NP (NN:[748..760] oleandomycin)))))))
        (CC:[761..764] but)
        (VP (RB:[765..768] not)
          (PP=1 (IN:[769..773] with)
            (NP (NN:[775..795] 3-methylcholanthrene) (,:[795..796] ,)
                (NN:[797..806] imidazole) (,:[806..807] ,)
                (NN:[808..815] ethanol) (,:[815..816] ,)
                (NN:[817..827] isosafrole) (,:[827..828] ,)
                (NN:[829..838] josamycin) (,:[838..839] ,)
                (NN:[840..851] midecamycin) (,:[851..852] ,) (CC:[853..855] or)
                (NN:[857..867] miocamycin))))))
    (.:[867..868] .)))

;sentence 6 Span:869..1006
;The activity of erythromycin N-demethylase correlated with the  content of
;the immunoreactive protein in rat liver microsomes (r = 0.72).
;[885..911]:substance:"erythromycin N-demethylase"
;[963..970]:substance:"protein"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[869..872] The) (NN:[873..881] activity))
      (PP (IN:[882..884] of)
        (NP (NN:[885..897] erythromycin) (NN:[898..899] N) (HYPH:[899..900] -)
            (NN:[900..911] demethylase))))
    (VP (VBD:[912..922] correlated)
      (PP-CLR (IN:[923..927] with)
        (NP
          (NP (DT:[928..931] the) (NN:[933..940] content))
          (PP (IN:[941..943] of)
            (NP
              (NP (DT:[944..947] the) (JJ:[948..962] immunoreactive)
                  (NN:[963..970] protein))
              (PP-LOC (IN:[971..973] in)
                (NP (NN:[974..977] rat) (NN:[978..983] liver)
                    (NNS:[984..994] microsomes)))))))
      (PRN (-LRB-:[995..996] -LRB-)
        (S
          (NP-SBJ (NN:[996..997] r))
          (VP (SYM:[998..999] =)
            (NP (CD:[1000..1004] 0.72))))
        (-RRB-:[1004..1005] -RRB-)))
    (.:[1005..1006] .)))

;sentence 7 Span:1007..1150
;In  addition, anti-P-450 HFLa IgG inhibited erythromycin N-demethylase in
;liver  microsomes from erythromycin- or oleandomycin-pretreated rats.
;[1021..1040]:substance:"anti-P-450 HFLa IgG"
;[1051..1077]:substance:"erythromycin N-demethylase"
;[1104..1116]:substance:"erythromycin"
;[1121..1133]:substance:"oleandomycin"
(SENT
  (S
    (PP (IN:[1007..1009] In)
      (NP (NN:[1011..1019] addition)))
    (,:[1019..1020] ,)
    (NP-SBJ
      (NML (AFX:[1021..1025] anti) (HYPH:[1025..1026] -) (NN:[1026..1031] P-450))
      (NN:[1032..1036] HFLa) (NN:[1037..1040] IgG))
    (VP (VBD:[1041..1050] inhibited)
      (NP (NN:[1051..1063] erythromycin) (NN:[1064..1065] N)
          (HYPH:[1065..1066] -) (NN:[1066..1077] demethylase))
      (PP-LOC (IN:[1078..1080] in)
        (NP
          (NP (NN:[1081..1086] liver) (NNS:[1088..1098] microsomes))
          (PP (IN:[1099..1103] from)
            (NP
              (NP
                (ADJP (NN:[1104..1116] erythromycin) (HYPH:[1116..1117] -)
                  (ADJP-1 (-NONE-:[1117..1117] *P*)))
                (NML-2 (-NONE-:[1117..1117] *P*)))
              (CC:[1118..1120] or)
              (NP
                (ADJP (NN:[1121..1133] oleandomycin) (HYPH:[1133..1134] -)
                  (ADJP-1 (VBN:[1134..1144] pretreated)))
                (NML-2 (NNS:[1145..1149] rats))))))))
    (.:[1149..1150] .)))

;sentence 8 Span:1151..1367
;Furthermore, the  content of the immunoreactive protein highly correlated
;with that of P-450 PB-1,  which is distinct from Waxman's terminology, and is
;one of the forms of  PCN-inducible cytochrome P-450s (r = 0.95).
;[1199..1206]:substance:"protein"
;[1238..1248]:cyp450:"P-450 PB-1"
;[1324..1327]:substance:"PCN"
;[1338..1355]:cyp450:"cytochrome P-450s"
(SENT
  (S
    (ADVP (RB:[1151..1162] Furthermore))
    (,:[1162..1163] ,)
    (NP-SBJ
      (NP (DT:[1164..1167] the) (NN:[1169..1176] content))
      (PP (IN:[1177..1179] of)
        (NP (DT:[1180..1183] the) (JJ:[1184..1198] immunoreactive)
            (NN:[1199..1206] protein))))
    (VP
      (VP
        (ADVP (RB:[1207..1213] highly))
        (VBD:[1214..1224] correlated)
        (PP-CLR (IN:[1225..1229] with)
          (NP
            (NP (DT:[1230..1234] that))
            (PP (IN:[1235..1237] of)
              (NP
                (NP (NN:[1238..1243] P-450) (NN:[1244..1248] PB-1))
                (,:[1248..1249] ,)
                (SBAR
                  (WHNP-1 (WDT:[1251..1256] which))
                  (S
                    (NP-SBJ-1 (-NONE-:[1256..1256] *T*))
                    (VP (VBZ:[1257..1259] is)
                      (ADJP-PRD (JJ:[1260..1268] distinct)
                        (PP (IN:[1269..1273] from)
                          (NP
                            (NP (NNP:[1274..1280] Waxman) (POS:[1280..1282] 's))
                            (NN:[1283..1294] terminology))))))))))))
      (,:[1294..1295] ,) (CC:[1296..1299] and)
      (VP (VBZ:[1300..1302] is)
        (NP-PRD
          (NP (CD:[1303..1306] one))
          (PP (IN:[1307..1309] of)
            (NP
              (NP (DT:[1310..1313] the) (NNS:[1314..1319] forms))
              (PP (IN:[1320..1322] of)
                (NP
                  (ADJP (NN:[1324..1327] PCN) (HYPH:[1327..1328] -)
                        (JJ:[1328..1337] inducible))
                   (NN:[1338..1348] cytochrome) (NNS:[1349..1355] P-450s)))))))
      (PRN (-LRB-:[1356..1357] -LRB-)
        (S
          (NP-SBJ (NN:[1357..1358] r))
          (VP (SYM:[1359..1360] =)
            (NP (CD:[1361..1365] 0.95))))
        (-RRB-:[1365..1366] -RRB-)))
    (.:[1366..1367] .)))

;sentence 9 Span:1368..1525
;From these results and the results  reported so far, it seems possible that
;P-450 HFLa is one of the forms of  cytochrome P-450 inducible by
;glucocorticoids.
;[1444..1454]:cyp450:"P-450 HFLa"
;[1479..1495]:cyp450:"cytochrome P-450"
;[1509..1524]:substance:"glucocorticoids"
(SENT
  (S
    (PP (IN:[1368..1372] From)
      (NP
        (NP (DT:[1373..1378] these) (NNS:[1379..1386] results))
        (CC:[1387..1390] and)
        (NP
          (NP (DT:[1391..1394] the) (NNS:[1395..1402] results))
          (VP (VBN:[1404..1412] reported)
            (NP (-NONE-:[1412..1412] *))
            (ADVP (RB:[1413..1415] so) (RB:[1416..1419] far))))))
    (,:[1419..1420] ,)
    (NP-SBJ
      (NP (PRP:[1421..1423] it))
      (SBAR-1 (-NONE-:[1423..1423] *EXP*)))
    (VP (VBZ:[1424..1429] seems)
      (ADJP-PRD (JJ:[1430..1438] possible)
        (SBAR-1 (IN:[1439..1443] that)
          (S
            (NP-SBJ (NN:[1444..1449] P-450) (NN:[1450..1454] HFLa))
            (VP (VBZ:[1455..1457] is)
              (NP-PRD
                (NP (CD:[1458..1461] one))
                (PP (IN:[1462..1464] of)
                  (NP
                    (NP
                      (NP (DT:[1465..1468] the) (NNS:[1469..1474] forms))
                      (PP (IN:[1475..1477] of)
                        (NP (NN:[1479..1489] cytochrome) (NN:[1490..1495] P-450))))
                    (ADJP (JJ:[1496..1505] inducible)
                      (PP (IN:[1506..1508] by)
                        (NP (NNS:[1509..1524] glucocorticoids))))))))))))
    (.:[1524..1525] .)))

;section 10 Span:1529..1573
;PMID: 3395131 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1529..1533] PMID) (::[1533..1534] :) (CD:[1535..1542] 3395131)
        (NN:[1543..1544] -LSB-) (NNP:[1544..1550] PubMed) (::[1551..1552] -)
        (NN:[1553..1560] indexed) (IN:[1561..1564] for)
        (NNP:[1565..1573] MEDLINE-RSB-)))
